BALAXI HEALTHCARE DOMINICANA SRL — Captopril Importer Profile
Pharmaceutical Importer · #9 buyer for Captopril · $89.5K import value · 13 shipments · DOMINICAN REPULIC · DGFT Verified
BALAXI HEALTHCARE DOMINICANA SRL is the #9 importer of Captopril from India with $89.5K in import value and 13 verified shipments. BALAXI HEALTHCARE DOMINICANA SRL holds a 0.7% market share in Captopril imports based in DOMINICAN REPULIC. The company sources from 2 verified suppliers across 12 formulations shipped to 2 countries. Overall, BALAXI HEALTHCARE DOMINICANA SRL imports 3 pharmaceutical products worth $1.1M across 3 therapeutic categories.
BALAXI HEALTHCARE DOMINICANA SRL — Captopril Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Captopril to BALAXI HEALTHCARE DOMINICANA SRL?
Verified from 13 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| BALAXI PHARMACEUTICALS LIMITED | $78.2K | 11 | 87.4% |
| BALAXI VENTURES LIMITED | $11.3K | 2 | 12.6% |
BALAXI HEALTHCARE DOMINICANA SRL sources Captopril from 2 verified Indian suppliers based on 13 customs records. The primary supplier is BALAXI PHARMACEUTICALS LIMITED accounting for 87.4% of imports.
How Does BALAXI HEALTHCARE DOMINICANA SRL Compare to Nearest Captopril Importers?
Buyers ranked immediately above and below #9 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | HEKO PHARMACY LIMITED | TANZANIA | $137.6K | 5 | $27.5K |
| 8 | M/S.RWANDA MEDICAL SUPPLY LTD. | RWANDA | $93.5K | 2 | $46.7K |
| 9 | BALAXI HEALTHCARE DOMINICANA SRL ★ | DOMINICAN REPUBLIC | $89.5K | 13 | $6.9K |
| 10 | AJANTA PHARMA USA INC | UNITED STATES | $71.4K | 5 | $14.3K |
| 11 | SAUDI HOSPITAL IN HAJJAH(SHH) | YEMEN | $67.7K | 6 | $11.3K |
BALAXI HEALTHCARE DOMINICANA SRL ranks #9 among 170 Captopril importers from India. Average shipment value of $6.9K compared to the market average of $17.2K. The closest competitors by value are HEKO PHARMACY LIMITED and M/S.RWANDA MEDICAL SUPPLY LTD..
Where Does BALAXI HEALTHCARE DOMINICANA SRL Import Captopril To?
Destination countries from 13 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| DOMINICAN REPULIC | $52.9K | 9 | 59.1% |
| DOMINICAN REPUBLIC | $36.6K | 4 | 40.9% |
BALAXI HEALTHCARE DOMINICANA SRL imports Captopril to 2 countries. The primary destination is DOMINICAN REPULIC receiving 59.1% of shipments worth $52.9K.
What Captopril Formulations Does BALAXI HEALTHCARE DOMINICANA SRL Import?
| Formulation | Value | Shipments |
|---|---|---|
| CAPTOPRIL TABLETS 25 MG (GSTIN-02AACCB8447R2Z8/TAX INVOICE NO.BT014/2526) (PACKING-10X10) (10000 TABS/CTN - 10X10X10X10) | $12.7K | 1 |
| CAPTOPRIL TABLETS 25 MG (GSTIN-02AACCB8447R2Z8/TAX INVOICE NO.BT017/2526) (PACKING-10X10) (10000 TABS/CTN - 10X10X10X10) | $12.7K | 1 |
| CAPTOPRIL TABLETS 25 MG GSTIN 02AACCB8447R2Z8 TAX INVOICE NO BT028 2526 PACKING 10X10 10000 TABS CTN 10X10X10X10 | $11.8K | 2 |
| CAPTOPRIL TABLETS 25 MG GSTIN-02AACCB8447R2Z8/TAX DOCUMENT NO.BT093/2324 PACKING-10X10 10000 TABS/CTN - 10X10X10X10 | $10.6K | 1 |
| CAPTOPRIL TABLETS 25 MG (GSTIN-02AACCB8447R2Z8/TAX INVOICE NO.BT251/2324) (PACKING-10X10) (10000 TABS/CTN - 10X10X10X10)TBS | $10.5K | 1 |
| CAPTOPRIL TABLETS 50 MG (GSTIN-02AACCB8447R2Z8/TAX INVOICE NO.BT042/2425) (PACKING-10X10) (10000 TABS/CTN - 10X10X10X10) | $10.2K | 1 |
| CAPTOPRIL TABLETS 50 MG (GSTIN-02AACCB8447R2Z8/TAX INVOICE NO.BT019/2425) (PACKING-10X10) (10000 TABS/CTN - 10X10X10X10) | $9.7K | 1 |
| CAPTOPRIL TABLETS 25 MG (GSTIN-02AACCB8447R2Z8/TAX INVOICE NO.BT282/2324) (PACKING-10X10) (10000 TABS/CTN - 10X10X10X10) | $3.5K | 1 |
| CAPTOPRIL TABLETS 25 MG (GSTIN-02AACCB8447R2Z8/TAX INVOICE NO.BT067/2425) (PACKING-10X10) (10000 TABS/CTN - 10X10X10X10) | $3.5K | 1 |
| CAPTOPRIL TABLETS 25 MG (GSTIN-02AACCB8447R2Z8/TAX INVOICE NO.BT042/2425) (PACKING-10X10) (10000 TABS/CTN - 10X10X10X10) | $3.2K | 1 |
BALAXI HEALTHCARE DOMINICANA SRL imports 12 distinct Captopril formulations from India. The top formulation is CAPTOPRIL TABLETS 25 MG (GSTIN-02AACCB8447R2Z8/TAX INVOICE N with 1 shipments worth $12.7K.
Who Are the Top Buyers of Captopril from India and How Much Does BALAXI HEALTHCARE DOMINICANA SRL Import?
India exported $2.9M worth of Captopril through 517 shipments from 109 suppliers to 63 countries, serving 170 buyers globally. BALAXI HEALTHCARE DOMINICANA SRL imports $89.5K of this total, accounting for 0.7% of India's Captopril exports with 13 shipments from DOMINICAN REPULIC. This is verified from 13 customs shipment records covering 12 distinct formulations.
What Is the Average Order Value for BALAXI HEALTHCARE DOMINICANA SRL's Captopril Imports?
BALAXI HEALTHCARE DOMINICANA SRL's average Captopril order value is $6.9K per consignment, based on 13 shipments totaling $89.5K. BALAXI HEALTHCARE DOMINICANA SRL is based in DOMINICAN REPULIC and ranks #9 among all Captopril importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Captopril to BALAXI HEALTHCARE DOMINICANA SRL?
BALAXI HEALTHCARE DOMINICANA SRL sources Captopril from 2 verified Indian suppliers: BALAXI PHARMACEUTICALS LIMITED ($78.2K, 87.4%), BALAXI VENTURES LIMITED ($11.3K, 12.6%). This is based on 13 customs records.
How Does BALAXI HEALTHCARE DOMINICANA SRL Compare to Other Captopril Importers?
BALAXI HEALTHCARE DOMINICANA SRL ranks #9 among 170 Captopril importers from India with a 0.7% market share. The top 3 importers are AJANTA PHARMA USA INC. C/O RXCROSSR ($1.1M), HEKO PHARMACY LTD ($336.7K), UNIQUE PHARMA, ($232.1K). BALAXI HEALTHCARE DOMINICANA SRL processed 13 shipments from DOMINICAN REPULIC.
About BALAXI HEALTHCARE DOMINICANA SRL
BALAXI HEALTHCARE DOMINICANA SRL imports 3 products worth $1.1M. Beyond Captopril, top products include Nystatin, Ranitidine. View the complete BALAXI HEALTHCARE DOMINICANA SRL profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Captopril — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Captopril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: BALAXI HEALTHCARE DOMINICANA SRL matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as BALAXI HEALTHCARE DOMINICANA SRL's capped import value divided by total capped export value for Captopril across all Indian exporters.
- 5.Verified Records: This page is backed by 13 individual customs records matching BALAXI HEALTHCARE DOMINICANA SRL importing Captopril, covering 12 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 63+ countries, 170+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Captopril Import Data for BALAXI HEALTHCARE DOMINICANA SRL
Access order-level details, pricing data, supplier connections, and competitive analysis for BALAXI HEALTHCARE DOMINICANA SRL's Captopril imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BALAXI HEALTHCARE DOMINICANA SRL
Full Company Profile →
3 products · $1.1M total trade · 3 categories
BALAXI HEALTHCARE DOMINICANA SRL × Captopril
Verified from customs records
Company Overview
Top Products by BALAXI HEALTHCARE DOMINICANA SRL
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for BALAXI HEALTHCARE DOMINICANA SRL.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Captopril. For current order-level data, contact TransData Nexus.